Browse > Article
http://dx.doi.org/10.4046/trd.2009.67.4.325

The Influence of Adverse Drug Reactions on First-line Anti-tuberculosis Chemotherapy in the Elderly Patients  

Jeong, Jeong Ihm (Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine)
Jung, Bock Hyun (Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine)
Kim, Mi Hye (Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine)
Lim, Jae Min (Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine)
Ha, Dong Cheon (Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine)
Cho, Sung-Won (Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine)
Rhui, Dae Sik (Department of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.67, no.4, 2009 , pp. 325-330 More about this Journal
Abstract
Background: Pulmonary tuberculosis (TB) is still common disease among the elderly patients in Korea where the overall incidence of TB is decreasing. Adverse drug reactions (ADR) associated with anti-TB drugs occurs frequently. Especially the aged tends to have more frequent ADRs than younger ones. These ADRs can cause significant morbidity, compromise therapeutic effects of drugs and even induce drug resistance. Therefore we evaluated the effect of ADRs on the first-line anti-TB drugs in elderly patients with active pulmonary TB. Methods: We retrospectively reviewed the charts and radiological findings of the patients with 65 and older who were bacteriologically confirmed as active TB and treated with standard anti-TB drugs for at least 6 months. Major ADR was defined with temporary or continuous stop of any first-line drugs intake. Results: An ADR was noted in 54% of all patients. The incidence of major ADR was 32% in all elderly patients. Dermatologic ADR (9%) was the most common among the major ADRs. GI trouble (8%), arthralgia (6%), visual change (6%), hepatotoxicity (4%), and fever (1%) were also noted. The drugs responsible for major ADR were ethambutol (62%), pyrazinamide (35%), rifampin (18%) and isoniazid (9%). Major ADRs were associated with higher ESR level at the initiation of anti-TB drugs. Conclusion: First-line anti-TB drugs in elderly patients frequently caused the major ADRs. Therefore the elderly patients receiving anti-TB drugs should be closely monitored and better tolerable therapy should be considered as part of a TB research agenda.
Keywords
Anti-tuberculosis treatment; Drug toxicity; Aged; ESR;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Korea Center for Disease Control and Prevention, Korean Institute of Tuberculosis. Annual report on the notified tuberculosis patients in Korea: based on Korean Tuberculosis Surveillance System, 2006. Seoul: Korean Institute of Tuberculosis; 2007
2 Stead WW, Dutt AK. Tuberculosis in elderly persons. Annu Rev Med 1991;42:267-76   DOI   ScienceOn
3 Dutt AK, Stead WW. Tuberculosis in the elderly. Med Clin North Am 1993;77:1353-68   DOI   PUBMED
4 Counsell SR, Tan JS, Dittus RS. Unsuspected pulmonary tuberculosis in a community teaching hospital. Arch Intern Med 1989;149:1274-8   DOI   ScienceOn
5 World Health Organization. Treatment of tuberculosis: guidelines for national programs. WHO/CDS/TB 2003. 313. Geneva: World Health Organization; 2003
6 Kang YJ, Lim SY, Shin JW, Choi JS, Yoo JH, Park IW, et al. Follow-up study of 6-month short course chemotherapy for pulmonary tuberculosis with 2SKHRZ/4HRZ. Tuberc Respir Dis 1996;43:852-61   DOI
7 Teale C, Goldman JM, Pearson SB. The association of age with the presentation and outcome of tuberculosis: a five-year survey. Age Ageing 1993;22:289-93   DOI   ScienceOn
8 Lee JH, Han DH, Song JW, Chung HS. Diagnostic and therapeutic problems of pulmonary tuberculosis in elderly patients. J Korean Med Sci 2005;20:784-9   DOI   ScienceOn
9 Kim SH, Lee BH, Lee KD, Park JS, Kim YS, Jee YK, et al. The prevalence of adverse drug reactions to a short course anti-tuberculosis regimen. Korean J Med 2007;73:496-502
10 Schaberg T, Rebhan K, Lode H. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996;9:2026-30   DOI   ScienceOn
11 National Tuberculosis and Respiratory Disease Association. Diagnostic standards and classification of tuberculosis. 12th ed. New York: National Tuberculosis and Respiratory Disease Association; 1969
12 Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003;167:1472-7   DOI   PUBMED   ScienceOn
13 Ministry of Health & Welfare, Korean National Tuber-culosis Association. Report on the 7th tuberculosis prevalence survey in Korea. Seoul: Korean National Tuberculosis Association; 1996